SC 13G/A: Cyclerion Therapeutics, Inc.

AI Summary

SC 13G/A filing by Cyclerion Therapeutics, Inc..

Risk Assessment

Risk Level: low

FAQ

Filing Documents

• d817118dsc13ga.htm (SC 13G/A) — 160KB
• 0001193125-24-178653.txt ( ) — 162KB

(a)

Item 1(a). Name of Issuer: Cyclerion Therapeutics, Inc. (the Issuer)

(b)

Item 1(b). Address of Issuers Principal Executive Offices: 245 First Street, 18th Floor, Cambridge, Massachusetts 02142

(a)

Item 2(a). Name of Person Filing:

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence:

(c)

Item 2(c). Citizenship: (i) Invus Public Equities, L.P. (Invus Public Equities) 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Bermuda limited partnership (ii) Invus Public Equities Advisors, LLC (Invus PE Advisors) 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Delaware limited liability company (iii) Invus, L.P. 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Bermuda limited partnership (iv) Invus Advisors, L.L.C. (Invus Advisors) 750 Lexington Avenue, 30th Floor, New York, NY 10022 Citizenship: Delaware limited liability company (v) Artal International S.C.A. (Artal International) Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg Citizenship: Luxembourg limited partnership (vi) Artal International Management S.A. (Artal International Management) Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg Citizenship: Luxembourg société anonyme (vii) Artal Group S.A. (Artal Group) Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg Citizenship: Luxembourg société anonyme (viii) Westend S.A. (Westend) Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg Citizenship: Luxembourg société anonyme (ix) Stichting Administratiekantoor Westend (the Stichting) Claude Debussylaan, 46, 1082 MD Amsterdam, The Netherlands Citizenship: Netherlands foundation (x) Mr. Amaury Wittouck Valley Park, 44, Rue de la Vallée, L-2661, Luxembourg Citizenship: Belgium The foregoing persons are hereinafter sometimes collectively referred to as the Reporting Persons.

(d)

Item 2(d). Title of Class of Securities: Common Stock, no par value (the Shares)

(e)

Item 2(e). CUSIP Number: 23255M105 12 Item3. If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing Is a(n): This

is not applicable

Item 3 is not applicable. Item4. (a) Amount beneficially owned: Invus Public Equities directly holds 115,603 Shares and Invus, L.P. directly holds 552 Shares. Invus PE Advisors, as the general partner of Invus Public Equities, controls Invus Public Equities and, accordingly, may be deemed to beneficially own the Shares directly held by Invus Public Equities. Invus Advisors as the general partner of Invus, L.P. controls Invus, L.P. and, accordingly, may be deemed to beneficially own the Shares directly held by Invus, L.P. The Geneva branch of Artal International, as the managing member of Invus PE Advisors, controls Invus PE Advisors and, accordingly, may be deemed to beneficially own the Shares that Invus PE Advisors may be deemed to beneficially own. Artal International, as the managing member of Invus Advisors, controls Invus Advisors and, accordingly, may be deemed to beneficially own the Shares that Invus Advisors may be deemed to beneficially own. Artal International Management, as the managing partner of Artal International, controls Artal International and, accordingly, may be deemed to beneficially own the Shares that Artal International may be deemed to beneficially own. Artal Group, as the sole stockholder of Artal International Management, controls Artal International Management and, accordingly, may be deemed to beneficially own the Shares that Artal International Management may be deemed to beneficially own. Westend, as the parent company of Artal Group, controls Artal Group and, accordingly, may be deemed to beneficially own the Shares that Artal Group may be deemed to beneficially own. The Stichting, as the majority stockholder of Westend, controls Westend and, accordingly, may be deemed to beneficially own the Shares that Westend may be deemed to beneficially own. Mr. Wittouck, as the sole member of the board of the Stichting, controls the Stichting and, accordingly, may be deemed to beneficially own the Shares that the Stichting ma

View Full Filing

View this SC 13G/A filing on SEC EDGAR